“The effect of IRA on our business and the healthcare industry in general is not yet fully known. Adoption of price controls and cost-containment measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit our revenue generated from the sale of any approved products”
All entries for: Cerevel Therapeutics
October 1, 2023
Cerevel Therapeutics
Negative Outlook
Cambridge, MA
201-500 employees
201-500 employees
Disease Area: Neurological Diseases
Drug Type: Small Molecule
August 2, 2023
Cerevel Therapeutics
Negative Outlook
Cambridge, MA
201-500 employees
201-500 employees
Disease Area: Neurological Diseases
Drug Type: Small Molecule
May 3, 2023
Cerevel Therapeutics
Negative Outlook
Cambridge, MA
201-500 employees
201-500 employees
Disease Area: Neurological Diseases
Drug Type: Small Molecule
November 8, 2022
Cerevel Therapeutics
Negative Outlook
Cambridge, MA
201-500 employees
201-500 employees
Impact TBD: “The effect of IRA on our business and the healthcare industry in general is not yet known. Adoption of price controls and cost-containment measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit a company’s revenue generated from the sale of any approved products. Even if we do receive a favorable coverage determination for our products by third-party payors, coverage policies and third-party payor reimbursement rates may change at any time”
Disease Area: Neurological Diseases
Drug Type: Small Molecule
